Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Other
This study is looking at the long term outcomes and impact of treatment for triple negative breast cancer. The study is only open to those people with triple negative breast cancer who took part in the BEATRICE trial.
The BEATRICE trial looked at bevacizumab (Avastin) alongside standard chemotherapy as treatment for people with triple negative breast cancer.
Recruitment start: 30 October 2014
Recruitment end: 3 December 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor David Cameron
Experimental Cancer Medicine Centre (ECMC)
Leeds Institute of Clinical Trials Research (University of Leeds)
NIHR Clinical Research Network: Cancer
Roche
University of Leeds
Last reviewed: 6 December 2017
CRUK internal database number: 12744
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
